Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04443192Phase 1Terminated
A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects
Alpha1 Anti-Trypsin Deficiency
PrincipalinvestigatorStart date: 2020-08-03

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

MAC Clinical Research

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mark Brantly, MD

University of Florida

Moderately Similar
3 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

John Magee, MD

University of Michigan Medical Center, Ann Arbor

Moderately Similar
3 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

David A. Brenner, MD

The University of California, San Diego

Moderately Similar
1 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Averell Sherker, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Moderately Similar
11 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Lisa Henn, PhD

Arbor Research Collaborative of Health

Moderately Similar
1 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Charlton Strange, MD

Medical University of South Carolina, Charleston, SC, USA

Moderately Similar
2 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Charlie Strange, MD

Medical University of South Carolina

Moderately Similar
6 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Donald Schmechel, MD

Southeast Neurology and Memory Clinic

Moderately Similar
1 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Noel G. McElvaney, MB, BCh, BAO

Beaumont Hospital, Dublin, Ireland

Moderately Similar
1 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Jeanine D'Armiento, MD, PhD

Alpha-1 Foundation

Moderately Similar
2 trials

Shared therapeutic areas:

Alpha-1 Antitrypsin Deficiency
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04443192Phase 1PrincipalInvestigator

A Single Ascending and Repeated Dose Study of Oral ZF874 in Healthy Volunteers and PiXZ Subjects

Alpha1 Anti-Trypsin Deficiency
Terminated

All 1 trials loaded